Test directory: HTLV I/II Ab, Western Blot

Ordering Code 5088
Test Name HTLV I/II Ab, Western Blot
Preferred Specimen Serum
Preferred Container SST (Gold)
Other Specimen/Container Plasma in Citrate, 3.2% (Lt. Blue), Plasma in Lithium
Heparin (Green), Plasma in Sodium Heparin (Green), Serum in
Plain (Red), Whole Blood in EDTA, K2 (Lavender)
Optimum Volume 1 mL
Handling Instructions Centrifuge and separate within 2 hours of collection
Transport Requirements Oahu: Refrigerated
Airline: Refrigerated
Specimen Stability Ambient: Not Stable
Refrigerated: 7 Days
Frozen: Indefinitely (avoid freeze/thaw cycle)
Rejection Criteria Avoid thaw/freeze
Avail. Stat NO
Analytic Time Up to 8 Days
Methodology Qualitative Western Blot
Reference Lab  ARUP Laboratories

Reference range(s)

The reference ranges listed below are valid on this date of June 1, 2025.
Component Age Male Norm Male Critical Low Male Critical High Female Norm Female Critical High Female Critical Low Units Add'l info
HTLV I/II Ab, Western Blot ALL NEGATIVE NEGATIVE

HTLV-I/II...
HTLV-I/II Western Blot Pattern: (Key: 0 = neg, * = weak pos, 1 = moderate pos, 2 = strong pos, 3 = very strong pos, X = non-specific staining obscuring possible bands in that region)
INTERPRETIVE INFORMATION
This assay should not be used for blood doner screening, associated re-entry protocols, or for screening Human Cells,
Tissues and Cellular and Tissue-Based Products (HCT/P)

This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes
Note1

Note1:


HTLV-I/II Western Blot Pattern: (Key: 0 = neg, * = weak pos, 1 = moderate pos, 2 = strong pos, 3 = very strong pos, X = non-specific staining obscuring possible bands in that region)
INTERPRETIVE INFORMATION
This assay should not be used for blood doner screening, associated re-entry protocols, or for screening Human Cells,
Tissues and Cellular and Tissue-Based Products (HCT/P)

This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes
.